Inventors: Henry J. Kaminski, Linda L. Kusner, Namita Satiya
Summary: The neuromuscular junction is the synapse or junction of the axon terminal of a neuron within a muscle fiber plasma membrane. Several diseases involve the neuromuscular junction as the primary site of injury. Examples include myasthenia gravis, Lambert-Eaton syndrome and Miller Fischer syndrome. This invention relates to compositions and methods useful for targeting therapeutic agents to the neuromuscular junction using neuromuscular junction targeting peptides.
Patent: U.S. and foreign patents pending